[HTML][HTML] Accounting for underreporting in mathematical modeling of transmission and control of COVID-19 in Iran

…, H Hamedmoghadam, K Madani, HM Dolk… - Frontiers in …, 2020 - frontiersin.org
Iran has been the country most affected by the outbreak of SARS-CoV-2 in the Middle East.
With a relatively high case fatality ratio and limited testing capacity, the number of confirmed …

Dietary vitamin A and teratogenic risk: European Teratology Society discussion paper

HM Dolk, H Nau, H Hummler, SM Barlow - European Journal of Obstetrics & …, 1999 - Elsevier
This review discusses the predictive value of animal models in assessment of possible risk
from excess vitamin A consumption during pregnancy and the human evidence concerning …

The prevalence of congenital anomalies in Europe

H Dolk, M Loane, E Garne - Rare diseases epidemiology, 2010 - Springer
EUROCAT (European Surveillance of Congenital Anomalies) is the network of population-based
registers of congenital anomaly in Europe, with a common protocol and data quality …

Long term trends in prevalence of neural tube defects in Europe: population based study

…, C Dias, E Draper, E Garne, M Gatt, M Haeusler… - Bmj, 2015 - bmj.com
Study question What are the long term trends in the total (live births, fetal deaths, and terminations
of pregnancy for fetal anomaly) and live birth prevalence of neural tube defects (NTD) …

Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005

H Dolk, M Loane, E Garne… - Circulation, 2011 - Am Heart Assoc
Background— This study determines the prevalence of Congenital Heart Defects (CHD),
diagnosed prenatally or in infancy, and fetal and perinatal mortality associated with CHD in …

Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening

…, B Doray, E Garne, M Gatt, M Haeusler… - European Journal of …, 2013 - nature.com
This study examines trends and geographical differences in total and live birth prevalence
of trisomies 21, 18 and 13 with regard to increasing maternal age and prenatal diagnosis in …

Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?

H Dolk, J Jentink, M Loane, J Morris… - Neurology, 2008 - AAN Enterprises
Objective: To investigate whether first trimester exposure to lamotrigine (LTG) monotherapy
is specifically associated with an increased risk of orofacial clefts (OCs) relative to other …

Recommendations from the SCPE collaborative group for defining and classifying cerebral palsy

C Cans, H Dolk, MJ Platt, A Colver - … medicine and child …, 2007 - search.proquest.com
collaborative group for defining and Page 1 Recommendations from the SCPE collaborative
group for defining and classifying cerebral palsy cHRısTINE cANs MD PID", H. DoLk MD …

The impact of environmental pollution on congenital anomalies

H Dolk, M Vrijheid - British Medical Bulletin, 2003 - academic.oup.com
Major congenital anomalies are diagnosed in 2–4% of births. In this paper we review
epidemiological studies that have specifically looked at congenital anomalies as a possible …

[HTML][HTML] Valproic acid monotherapy in pregnancy and major congenital malformations

J Jentink, MA Loane, H Dolk, I Barisic… - … England Journal of …, 2010 - Mass Medical Soc
Background The use of valproic acid in the first trimester of pregnancy is associated with an
increased risk of spina bifida, but data on the risks of other congenital malformations are …